Turning Point Therapeutics, Inc.
Macrocycles for use in treating disease

Last updated:

Abstract:

The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer.

Status:
Grant
Type:

Utility

Filling date:

26 Mar 2021

Issue date:

12 Oct 2021